You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®

The product is approved for post-exposure prophylaxis against rabies infection

read more 

EVENTS

Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

A crowded symposium dedicated to the SIPPET Study was held on July 9th

read more 

EVENTS

Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017

Global campaign to improve early diagnosis and optimal treatments for PID

read more 
For more information please contact: pressoffice@kedrion.com